Edward Borkowski - 02 Jan 2024 Form 4 Insider Report for First Wave BioPharma, Inc. (ENTO)

Role
Director
Signature
/s/ Edward Borkowski
Issuer symbol
ENTO
Transactions as of
02 Jan 2024
Net transactions value
$0
Form type
4
Filing time
04 Jan 2024, 17:12:43 UTC
Previous filing
05 Jan 2023
Next filing
02 Oct 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FWBI Common Stock Award $0 +19,633 +3192% $0.000000 20,248 02 Jan 2024 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On January 2, 2024, the Reporting Person was granted 19,633 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest quarterly for one year with 25% vesting quarterly beginning April 1, 2024.
F2 Includes unvested RSUs.